{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:20:06Z","timestamp":1790256006914,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:00:00Z","timestamp":1372723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0067898","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T21:03:21Z","timestamp":1372799001000},"page":"e67898","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["A Luminex Assay Detects Amyloid \u03b2 Oligomers in Alzheimer\u2019s Disease Cerebrospinal Fluid"],"prefix":"10.1371","volume":"8","author":[{"given":"Adrianna Z.","family":"Herskovits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Locascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine R.","family":"Peskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"BT Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach","volume":"123","author":"TJ Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0072-9752(07)01224-9","article-title":"Biological CSF markers of Alzheimer\u2019s disease","volume":"89","author":"H Zetterberg","year":"2008","journal-title":"Handb Clin Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1096\/fj.09-150359","article-title":"High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients","volume":"24","author":"H Fukumoto","year":"2010","journal-title":"FASEB J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43)","volume":"13","author":"T Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"JT Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.90.22.10836","article-title":"beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease","volume":"90","author":"AE Roher","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/exnr.1996.0048","article-title":"Inhibition of age-induced beta-amyloid neurotoxicity in rat hippocampal cells","volume":"138","author":"PS Puttfarcken","year":"1996","journal-title":"Exp Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"MP Lambert","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"DM Walsh","year":"2002","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"S Lesn\u00e9","year":"2006","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease","volume":"27","author":"PN Lacor","year":"2007","journal-title":"J Neurosci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"GM Shankar","year":"2008","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer\u2019s disease: an emperor in need of clothes","volume":"15","author":"I Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-2012-111361","article-title":"Amyloid-beta oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer\u2019s disease","volume":"29","author":"AN Santos","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2012.09.014","article-title":"Amyloid-beta oligomer detection by ELISA in cerebrospinal fluid and brain tissue","volume":"433","author":"KA Bruggink","year":"2013","journal-title":"Anal Biochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2007-11114","article-title":"Detection of amyloid-beta oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer","volume":"11","author":"AN Santos","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.23748","article-title":"Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls","volume":"73","author":"TJ Esparza","year":"2013","journal-title":"Ann Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2012.11.005","article-title":"New ELISAs with high specificity for soluble oligomers of amyloid beta-protein detect natural Abeta oligomers in human brain but not CSF","volume":"9","author":"T Yang","year":"2013","journal-title":"Alzheimers Dement"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"P Buchhave","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/1567205011310040002","article-title":"A New Decision Tree Combining Abeta 1-42 and p-Tau Levels in Alzheimer\u2019s Diagnosis","volume":"10","author":"S Bombois","year":"2013","journal-title":"Curr Alzheimers Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","article-title":"Age and diagnostic performance of Alzheimer disease CSF biomarkers","volume":"78","author":"N Mattsson","year":"2012","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","article-title":"Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology","volume":"51","author":"A Olsson","year":"2005","journal-title":"Clin Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2012-121246","article-title":"Comparison of Two Analytical Platforms for the Clinical Qualification of Alzheimer\u2019s Disease Biomarkers in Pathologically-Confirmed Dementia","volume":"33","author":"N Le Bastard","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archneurol.2012.26","article-title":"Comparison of cerebrospinal fluid levels of tau and Abeta 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms","volume":"69","author":"DJ Irwin","year":"2012","journal-title":"Arch Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","article-title":"Comparison of analytical platforms for cerebrospinal fluid measures of beta-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology","volume":"68","author":"AM Fagan","year":"2011","journal-title":"Arch Neurol"},{"key":"ref27","first-page":"183","article-title":"Standardized multiparameter quantification of biomarkers for Alzheimer\u2019s disease in cerebrospinal fluid","author":"H Vanderstichele","year":"2005"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","article-title":"Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI","volume":"121","author":"LM Shaw","year":"2011","journal-title":"Acta Neuropathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer\u2019s Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"N Mattsson","year":"2011","journal-title":"Alzheimers Dement"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1074\/jbc.M511018200","article-title":"Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice","volume":"281","author":"EB Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-2-18","article-title":"Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers","volume":"2","author":"R Kayed","year":"2007","journal-title":"Mol Neurodegener"},{"key":"ref32","first-page":"189","article-title":""Mini-mental state". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"CP Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"ref34","article-title":"Manual: Wechsler memory scale","author":"D Wechsler","year":"1983"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"WJ Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010","volume":"71","author":"TG Beach","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s Disease Neuroimaging Initiative subjects","volume":"65","author":"LM Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbrc.2012.04.146","article-title":"Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for Abeta oligomers","volume":"422","author":"T Kasai","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","article-title":"Functions of Abeta, sAPPalpha and sAPPbeta : similarities and differences","volume":"120","author":"S Chasseigneaux","year":"2012","journal-title":"J Neurochem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/mp.2008.84","article-title":"Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer\u2019s disease: a multicenter study","volume":"15","author":"P Lewczuk","year":"2011","journal-title":"Mol Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.40.7.1028","article-title":"Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer\u2019s disease","volume":"40","author":"MR Palmert","year":"1990","journal-title":"Neurology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-4886(03)00027-X","article-title":"Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients","volume":"183","author":"A Olsson","year":"2003","journal-title":"Exp Neurol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000007917","article-title":"Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer\u2019s disease and major depression - inverse correlation with dementia severity","volume":"39","author":"C Hock","year":"1998","journal-title":"Eur Neurol"},{"key":"ref45","article-title":"Soluble amyloid precursor protein alpha and beta in CSF in Alzheimer\u2019s disease","author":"G Brinkmalm","year":"2013","journal-title":"Brain Res"},{"key":"ref46","first-page":"81","article-title":"Alzheimer\u2019s Disease Biomarkers: from Concept to Clinical Utility","year":"2008"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-60761-744-0_2","article-title":"Preparing synthetic Abeta in different aggregation states","volume":"670","author":"WB Stine","year":"2011","journal-title":"Methods Mol Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1073\/pnas.0409336102","article-title":"Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer\u2019s disease","volume":"102","author":"DG Georganopoulou","year":"2005","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0067898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:51:55Z","timestamp":1589039515000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0067898"}},"subtitle":[],"editor":[{"given":"Koichi\u00a0M","family":"Iijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,2]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0067898","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,2]]}}}